Concepedia

John McNally

JM

41

Publications

8.7K

Citations

34

H-Index

1985

Active since

Affiliations

Gilead Sciences (United States)(Current)

Johns Hopkins University

Goethe University Frankfurt

UNSW Sydney

Casa Sollievo della Sofferenza

John McNally is an author at Gilead Sciences (United States) specializing in medicine, hepatitis, and viral hepatitis.

Top concepts

Publications per year

1985–2022

41

Publications

41

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

Eric Lawitz, Alessandra Mangia, David Wyles et al. · New England Journal of Medicine · 2013 · 1.8K citations

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

Ira M. Jacobson, Stuart C. Gordon, Kris V. Kowdley et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 845 citations · Full text

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

Michael P. Curry, Jacqueline G. O’Leary, Natalie Bzowej et al. · New England Journal of Medicine · 2015 · 795 citations · Full text

Rows per page

1–5 of 41